Published in Haemostasis on January 01, 1976
Human parvovirus-associated arthritis: a clinical and laboratory description. Lancet (1985) 3.82
The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor. J Exp Med (1969) 2.39
Attitudes of patients to clinical teaching. Br J Med Educ (1967) 2.28
Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors. J Clin Invest (1969) 2.14
Postgraduate medical degrees of the University of Aberdeen, 1931-69. Scott Med J (1970) 1.64
Insulin as an amyloid-fibril protein at sites of repeated insulin injections in a diabetic patient. Diabetologia (1988) 1.60
Local gold toxicity. Br Med J (1976) 1.59
Plasma fibrinogen and plasminogen levels in health and in ischaemic heart disease. J Clin Pathol (1966) 1.55
Predicting changes in the distribution of sweating following thoracoscopic sympathectomy. Br J Surg (1997) 1.53
Endoscopic transthoracic sympathectomy in the treatment of hyperhidrosis. Ann Surg (1992) 1.51
Consistency of teaching in parallel surgical firms: an audit of student experience at one medical school. Med Educ (2000) 1.51
Venous thrombosis following strokes. Lancet (1972) 1.46
Familial thrombosis: inherited deficiency of antithrombin III. Br Med J (1978) 1.40
Studies on the blood fibrinolytic enzyme system following acute myocardial infarction. Clin Sci (1967) 1.26
Further medical education of Aberdeen graduates 1956-58. Br J Med Educ (1969) 1.18
Feasibility and morbidity of reversal of Hartmann's. Colorectal Dis (2005) 1.17
Deep venous thrombosis of the legs after strokes. Part I--incidence and predisposing factors. Br Med J (1976) 1.15
The assay of a plasma component necessary for the generation of a plasminogen activator in the presence of Hageman factor (Hageman factor co-factor). Br J Haematol (1971) 1.12
A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction. Lancet (1973) 1.11
Serum Mucoproteins and Plasma Fibrinolytic Activity in Coronary-artery Disease. Br Med J (1962) 1.10
The relationship between platelet aggregation and time interval after venepuncture. Thromb Diath Haemorrh (1974) 1.08
Present employment of University of Aberdeen medical graduates, 1956-58. Lancet (1969) 1.06
Influence of folate status on genomic DNA methylation in colonic mucosa of subjects without colorectal adenoma or cancer. Br J Cancer (2005) 1.05
The inhibition of urokinase by alpha 2 -macroglobulin. Clin Sci (1973) 0.97
Hypothalamic-pituitary-adrenal (HPA) axis function in patients receiving long-term intra-articular corticosteroids. Clin Rheumatol (1983) 0.97
An outbreak of Campylobacter enteritis--a rheumatological followup survey. J Rheumatol (1983) 0.97
The plasminogen content of thrombi. Thromb Diath Haemorrh (1966) 0.96
Studies on the fibrinolytic enzyme system in obesity. J Clin Pathol (1966) 0.94
The metabolism of Plasmodium berghei, the malaria parasite of rodents. 2. An effect of mepacrine on the metabolism of glucose by the parasite separated from its host cell. Biochem J (1961) 0.93
Evaluation of diagnostic significance of certain symptoms and physical signs in anaemic patients. Br Med J (1969) 0.92
Inhibitors of the fibrinolytic enzyme system in renal disease. Clin Sci (1970) 0.92
Is vasoactive intestinal peptide an inhibitory transmitter in the circular but not the longitudinal muscle of guinea-pig colon? J Pharm Pharmacol (1984) 0.92
Effect of oestriol on platelet adhesiveness and fibrinolysis in men. Lancet (1966) 0.91
Pyoderma faciale in a patient with Crohn's disease. Clin Exp Dermatol (1992) 0.91
Psychogenic purpura. Br Med J (1971) 0.91
Effect of exercise on platelet count, adhesion, and aggregation. Acta Haematol (1974) 0.91
Smoking may be associated with complications in diverticular disease. Br J Surg (1999) 0.90
Lymphogranuloma venereum as a cause of rectal strictures. Postgrad Med J (1998) 0.90
Platelet adhesiveness, coagulation, and fibrinolytic activity in obesity. J Clin Pathol (1972) 0.90
Factors influencing the prognosis in myelomatosis. Postgrad Med J (1971) 0.90
Deep venous thrombosis of the legs after strokes: Part 2-Natural history. Br Med J (1976) 0.90
High incidence of myelomatosis in North-East Scotland. Scott Med J (1973) 0.90
Sequential studies on components of the haemostatic mechanism in pregnancy with particular reference to the development of pre-eclampsia. Br J Obstet Gynaecol (1976) 0.90
Mefenamic acid: an under-rated antirheumatic? Curr Med Res Opin (1977) 0.89
The inhibition of tissue activator and urokinase by human plasma. Thromb Haemost (1982) 0.88
Methotrexate and the platelet count. Br J Cancer (1968) 0.88
Fournier's gangrene: an aetiological hypothesis. Br J Urol (1992) 0.88
Surface-mediated reactions in the formation of thrombin, plasmin and kallikrein. Br Med Bull (1978) 0.87
Coagulation and fibrinolysis in thyroid disease. Acta Haematol (1978) 0.87
Acetylator phenotype in spontaneous SLE and rheumatoid arthritis. Ann Rheum Dis (1979) 0.87
The inhibition by plasma of urokinase and tissue activator-induced fibrinolysis in pregnancy and the puerperium. Thromb Haemost (1983) 0.86
The surgical treatment of upper limb hyperhidrosis. Br J Dermatol (1986) 0.86
Safe surgery in sickle cell disease. Br J Surg (1991) 0.86
The fibrinolytic enzyme system in hepatic cirrhosis and malignant metastases. J Clin Pathol (1971) 0.86
Levamisole - a possible alternative to gold and penicillamine in the longterm treatment of rheumatoid arthritis? J Rheumatol (1982) 0.85
Arcus senilis and coronary artery disease. Am Heart J (1965) 0.85
Studies on an inhibitor of plasminogen activators in human platelets. Br J Haematol (1974) 0.85
Ankylosing spondylitis and an aortic arch syndrome. Br Heart J (1984) 0.85
The contribution of plasma protease inhibitors to antiplasmin activity in man. Clin Sci Mol Med (1976) 0.84
Abdominopelvic mass secondary to Actinomyces israelii mimicking cancer: report of two cases. Tech Coloproctol (2005) 0.84
Inhibitors of plasminogen activation in human blood. Br J Haematol (1976) 0.83
Blood levels of proteinase inhibitors in pre-eclampsia. Br J Obstet Gynaecol (1983) 0.83
Eicosanoid formation by mammalian intestine. Effects of some intestinal secretagogues. Eur J Pharmacol (1987) 0.83
Blood levels of proteinase inhibitors in pregnancy. Br J Obstet Gynaecol (1982) 0.83
The action of antithrombin III on plasmin and activators of plasminogen. Biochim Biophys Acta (1975) 0.82
Survey of methods of treatment of haemorrhoids and complications of injection sclerotherapy. Ann R Coll Surg Engl (2001) 0.82
Changes in protease inhibitors after acute myocardial infarction. J Clin Pathol (1976) 0.82
Patient compliance: a novel method of testing non-steroidal antiinflammatory analgesics in rheumatoid arthritis. J Rheumatol (1980) 0.81
Arterio-venous differences in the components of the fibrinolytic enzyme system. Thromb Diath Haemorrh (1966) 0.81
Eosinophilic fasciitis--a case with hypogammaglobulinaemia. Clin Exp Dermatol (1984) 0.81
C1 inactivator level in pregnancy. Thromb Res (1982) 0.80
The influence of the platelet count on the incidence of thrombotic and haemorrhagic complications in polycythaemia vera. Postgrad Med J (1970) 0.80
The effect of age on the fibrinolytic enzyme system. J Clin Pathol (1974) 0.80
Increased presence of serotonin-producing cells in colons with diverticular disease may indicate involvement in the pathophysiology of the condition. Int J Colorectal Dis (2006) 0.80
The influence of alpha-1-antitrypsin on plasmin, urokinase and Hageman factor cofactor. Biochim Biophys Acta (1974) 0.80
Endoscopic thoracic sympathectomy in the treatment of upper limb hyperhidrosis. Ann R Coll Surg Engl (1986) 0.80
Properties of a partially purified preparation of a circulating plasminogen activator. Thromb Res (1976) 0.79
Urokinase in iliofemoral venous thrombosis. Br J Surg (1969) 0.79
Endoscopic transthoracic sympathectomy for idiopathic upper limb hyperhidrosis. Clin Auton Res (1992) 0.78
Pseudosepsis in rheumatoid arthritis due to cellular and lipid abnormalities in synovial fluid. Br J Rheumatol (1992) 0.78
One lung ventilation in endoscopic transthoracic sympathectomy. J R Coll Surg Edinb (1994) 0.77
The fibrinolytic system in pre-eclampsia. J Clin Pathol (1984) 0.77
The effect of age upon the coagulation system. J Clin Pathol (1974) 0.77
Prevention of late haematogenous infection in major prosthetic joints. J Antimicrob Chemother (1989) 0.77
Platelet adhesiveness and fibrinolysis after recent cerebro-vascular accidents and their relationship with subsequent deep venous thrombosis of the legs. Thromb Haemost (1976) 0.77
The effect of prolonged exercise on the components of the blood fibrinolytic enzyme system. J Physiol (1968) 0.76
Endoscopic sympathectomy in the treatment of facial blushing. Ann R Coll Surg Engl (2005) 0.76
An evaluation of the diagnostic significance of some symptoms and physical signs in chronic iron-deficiency anaemia. Proc Nutr Soc (1969) 0.76
The effeCt of vitamin c supplements on serum cholesterol, coagulation, fibrinolysis and platelet adhesiveness. Atherosclerosis (1975) 0.76
The influence of the polyphenols of cider on plasmin and plasminogen activators. Br J Haematol (1985) 0.76
The poor cousin of medicine. Trop Doct (1994) 0.76
Pachydermodactyly: confused with JCA. Ann Rheum Dis (1992) 0.75
Biochemistry of the plasmin system. J Clin Pathol Suppl (R Coll Pathol) (1980) 0.75
The fibrinolytic enzyme system in hypertension. J Clin Pathol (1973) 0.75
Effect of local exercise and vessel occlusion on fibrinolytic activity. J Clin Pathol (1977) 0.75
Fibrinolytic activity in malignant disease. J Clin Pathol (1975) 0.75
Endoscopic transthoracic electrocautery of the sympathetic chain for palmar and axillary hyperhidrosis . Br J Surg (1990) 0.75